Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT.

Published in Government Relations on June 17, 2025

The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. 

Join industry experts Ronda Buhrmester, Kim Cuce’, Noel Neil, Zach Gantt, and Ray Gregg as they break down the key changes, explore the operational and financial impact on DME suppliers, and offer actionable strategies to navigate the new landscape. This session is essential for providers, billing teams, and clinicians working in the post-acute care space who need to stay ahead of regulatory shifts and ensure continuity of care for patients.  

Key Takeaways

  • Understand the new initial and continuing coverage criteria for RADs and HMVs 
  • Learn how to manage compliance and documentation under the new rule 
  • Explore the implications for hospital discharge planning and patient transitions 
  • Get tips for staff training, referral education, and revenue cycle adjustments 

Sign up here to view the webinar on June 25.


Victory for NY Medicaid: NEMEP Secures 100% Rate Floor 

HUGE WIN for NEMEP and NY Medicaid – 100% Rate Floor 

nemep

Posted by NEMEP on Friday, June 13, 2025 

Yesterday, the New York Senate passed long-sought Medicaid rate floor legislation, S. 1616, on a unanimous vote. The State Assembly affirmed a companion bill (A2520) earlier in the week, also by a unanimous tally. 
 
The bills require Medicaid managed care organizations (MCOs) to reimburse DME providers at no less than 100% of the state’s published Medicaid durable medical equipment and complex rehabilitation technology fee schedule. Currently, some MCOs reimburse DME providers at less than half of the Medicaid fee-for-service fee schedule for identical devices and supplies paid in the fee-for-service system. 
 
“By providing parity, this will ensure access when beneficiaries transfer from one MCO plan to another and prevent multiple reimbursement rates for the same item and service,” said John Quinlan, President of the Northeast Medical Equipment Providers (NEMEP) and President of Quinlan's Home Medical. “Setting rate parity will help protect access to care for NY Medicaid beneficiaries and support NY businesses who provide these valuable services.” 
 
“NEMEP, AAHomecare, VGM and other stakeholders advocated tirelessly for fair reimbursement that allows us to better support patients and reduce the time they spend in clinical or institutional settings,” continued Quinlan. “These sustained efforts ultimately paid off with unanimous support for rate floor legislation in both the Assembly and the Senate.” 
 
“The New York DME community thanks Assemblymember John McDonald III and Senator Gustavo Rivera for their steadfast support and leadership in securing unanimous passage,” said David Chandler, NEMEP Board Member and AAHomecare Vice President of Payer Relations.  
 
“I started working on this legislation with NEMEP leading up to its initial introduction in 2021, added Chandler. “We have gained momentum each legislative session since and have finally secured a big win that improves access to quality home-based care in New York state. The leaders at NEMEP deserve a lot of credit for their persistence in making the case for this policy though multiple sessions.”  
 
New York Governor Kathy Hochul has until December 31st to sign the measure into law. 

Beth Bowen, Executive Director adds, “NEMEP leadership has been tirelessly working toward this goal for years holding weekly lobbyist meetings with our solid team at Ostroff & Associates. Many trips to Albany pared with virtual sessions provided the advocacy we needed to set NEMEP providers up for success. A HUGE thank you to all who worked so hard to achieve this goal – it is apparent that with the unanimous vote, the lawmakers understand how important our industry is to the well-being of the beneficiaries in NY. We will update you when Governor Hochul signs into law!” 

From Our Experts

New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart.